LifeMD Q3 2026 net loss widens 23% year over year to $4.47 million
LFMD•LifeMD reported a third-quarter 2026 net loss of $4.47 million, up 23% year over year, while revenue fell 7% to $44.6 million. It cut full-year revenue guidance to $188 million–$191 million.
1. Quarterly results
Revenue fell 7% year over year to $44.6 million, below guidance, following deliberate marketing cuts and slower-than-expected partnership ramps. Net loss from continuing operations attributable to common stockholders narrowed 38% sequentially to $5.2 million.
2. Subscribers and outlook
Active subscribers rose 13% year over year to approximately 350,000 at quarter-end. LifeMD cut full-year 2026 revenue guidance to $188 million–$191 million and expects fourth-quarter revenue of $46 million–$49 million. An exclusive AT&T relationship gives its 100 million wireless and fiber customers access to healthcare and pharmacy services.
